<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37610356</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Expression patterns of T cells-specific long noncoding RNAs in systemic lupus erythematosus patients carrying HLA risk/nonrisk alleles.</ArticleTitle><Pagination><StartPage>1188</StartPage><EndPage>1198</EndPage><MedlinePgn>1188-1198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231196626</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long noncoding RNAs (LncRNAs) play key roles in the regulation of gene expression and subsequently in the pathogenesis of several autoimmune diseases. This study aimed to explore the peripheral expression levels of T-cells-specific LncRNAs and transcription factors in systemic lupus erythematosus (SLE) patients carrying either human leukocyte antigens (HLA) risk or non-risk alleles.</AbstractText><AbstractText Label="METHODS">Genotypes of <i>HLA-DRB1</i> and <i>HLA-DQB1</i> loci for 106 SLE patients were determined by PCR-SSP. In the next step, patients were stratified based on the presence of <i>HLA-DRB1*03</i> and/or <i>DRB1*16</i> allele groups (HLA risk alleles positive or HLA-R<sup><i>Pos</i></sup>) or carrying other <i>DRB1</i> allele groups (HLA-R<sup><i>Neg</i></sup>). Then, transcript levels of LncRNAs (<i>IFNG-AS1, RMRP, Th2LCR,</i> and <i>DQ786243</i>) and mRNAs for transcription factors (<i>Foxp3, Gata3,</i> and <i>Tbx21</i>) were measured using qRT-PCR and compared between two subgroups of patients.</AbstractText><AbstractText Label="RESULTS">Totally, 47 cases were classified as HLA-R<sup><i>Pos</i></sup> and 59 cases as HLA-R<sup><i>Neg</i></sup> patients. The HLA-R<sup><i>Pos</i></sup> patients showed decreased transcript levels of <i>DQ786243</i> (<i>p</i> = .001) and elevated expression of <i>IFNG-AS1</i> (<i>p</i> = .06) and <i>T-bet</i> mRNA (<i>p</i> = .03) compared to the HLA-R<sup><i>Neg</i></sup> group. We observed significantly lower expression of <i>Th2LCR</i> (<i>p</i> &lt; .0001) and <i>DQ786243</i> (<i>p</i> = .001) and higher expression of <i>Tbx21</i> (<i>p</i> = .009) and <i>Foxp3</i> (<i>p</i> = .02) in <i>DR3-</i>positive versus <i>DR3</i>-negative patients. Likewise, decreased transcript levels of <i>DQ786243</i> (<i>p</i> = .02) and <i>RMRP</i> (<i>p</i> = .003) were observed in <i>DR16-</i>positive versus <i>DR16</i>-negative patients. ROC curve analysis revealed the potential of <i>DQ786243</i> and <i>RMRP</i> as biomarkers in SLE disease based on the carriage of HLA risk alleles.</AbstractText><AbstractText Label="CONCLUSIONS">Our results indicate that the contribution of multiple T cell subsets in SLE disease progression as judged by expression analysis of LncRNAs and transcription factors can be inspired by the inheritance of HLA risk/nonrisk alleles is SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tahamoli-Roudsari</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Internal Diseases Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmani</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Immunology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshar</LastName><ForeName>Saeid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajilooi</LastName><ForeName>Mehrdad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Immunology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solgi</LastName><ForeName>Ghasem</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8929-5658</Identifier><AffiliationInfo><Affiliation>School of Medicine, Department of Immunology, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA alleles</Keyword><Keyword MajorTopicYN="N">LncRNAs expression</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37610356</ArticleId><ArticleId IdType="doi">10.1177/09612033231196626</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>